Junius Daniel M
- SEC CIK
- 0001094159
No open-market purchases or sales filed in the past year.
Current role at each company
- IDXX IDEXX Laboratories IncDirectoras of May 14, 2026
- CBIO Crescent Biopharma, Inc.Directoras of May 1, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Junius Daniel M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IDXX IDEXX Laboratories Inc
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 (view filing) | May 13 | 1 day | Junius Daniel MDirector | SSale | −2.68K | $506.41 | −$1.36M | −44.8%3.30K after | |
| Feb 17, 2023 (view filing) | Feb 16 | 1 day | Junius Daniel MDirector | SSale | −2.19K | $511.68 | −$1.12M | −42.3%2.98K after | |
| Dec 7, 2022 (view filing) | Dec 5 | 2 days | Junius Daniel MDirector | SSale | −3.05K | $424.91 | −$1.29M | −50.6%2.97K after | |
| Aug 12, 2021 (view filing) | Aug 10 | 2 days | Junius Daniel MDirector | SSale | −2.40K | $679.58 | −$1.63M | −45.3%2.90K after |
CBIO Crescent Biopharma, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2023 (view filing) | May 10 | 1 day | Junius Daniel MDirector | PPurchase | +30.0K | $1.56 | +$46.8K | +47.4%93.3K after | |
| Nov 18, 2022 (view filing) | Nov 17 | 1 day | Junius Daniel MDirector | PPurchase | +20.0K | $1.87 | +$37.4K | +46.2%63.3K after |